找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Critical Issues in Head and Neck Oncology; Key Concepts from th Jan B. Vermorken,Volker Budach,Brian O’Sullivan Conference proceedings‘‘‘‘‘

[復(fù)制鏈接]
樓主: burgeon
21#
發(fā)表于 2025-3-25 07:22:51 | 只看該作者
Promising Biomarkers for Early Diagnosis and Prognosis Prediction such as PDL-1 and NTRK are now finding applications in head and neck cancer care. Immunohistochemistry is an attractive option because of its rapid turnaround time and convenience but molecular testing is often necessary for validation. This chapter will focus on some selected biomarkers being deve
22#
發(fā)表于 2025-3-25 09:33:56 | 只看該作者
23#
發(fā)表于 2025-3-25 12:29:25 | 只看該作者
24#
發(fā)表于 2025-3-25 19:39:21 | 只看該作者
25#
發(fā)表于 2025-3-25 22:10:33 | 只看該作者
NK Cells in Immunotherapy: How Important Are They?totoxic mechanisms. Their functions can be very useful for cancer immunotherapy. But to achieve the maximum support from these extraordinary cells it is necessary to know their effector mechanisms and the mechanisms that lead to their suppression. We have briefly summarized some interesting aspect o
26#
發(fā)表于 2025-3-26 01:26:47 | 只看該作者
27#
發(fā)表于 2025-3-26 06:15:22 | 只看該作者
Novel Approaches in Surgical Management: How to Assess Surgical Marginshe recommendations on margins management relies on two pillars: (1) the observation that groups of cancer cells can leave the macroscopic tumor and disseminate throughout adjacent tissues with different degrees of aggressiveness; (2) the belief that removal of all (or most of) cancer cells can cure
28#
發(fā)表于 2025-3-26 09:26:30 | 只看該作者
29#
發(fā)表于 2025-3-26 13:32:34 | 只看該作者
30#
發(fā)表于 2025-3-26 17:44:50 | 只看該作者
High-Dose Three-Weekly or Low-Dose Weekly Cisplatin during Radiation, What to Prefer?ve or adjuvant radiotherapy can significantly improve locoregional control and survival. One of the major drawbacks is severe acute toxicity with about 40% of patients developing mucositis, up to one fourth suffering from dysphagia, and at least 20% having bone marrow suppression. Late toxicity has
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 09:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宜都市| 郑州市| 洛南县| 呼伦贝尔市| 武夷山市| 防城港市| 玉溪市| 和政县| 南阳市| 修水县| 逊克县| 朝阳区| 景洪市| 晋江市| 原平市| 新晃| 信丰县| 涞水县| 聂荣县| 通化县| 乐都县| 铜梁县| 旌德县| 景洪市| 深州市| 凤冈县| 晋城| 宜昌市| 苍梧县| 朝阳县| 湛江市| 石嘴山市| 洞口县| 保靖县| 噶尔县| 富裕县| 茶陵县| 花垣县| 安化县| 永春县| 南昌县|